$105.90
2.28% today
NYSE, Feb 05, 04:16 pm CET
ISIN
US1011371077
Symbol
BSX

Boston Scientific Stock price

$103.54
+12.25 13.42% 1M
+30.58 41.91% 6M
+14.22 15.92% YTD
+39.08 60.63% 1Y
+60.77 142.09% 3Y
+60.66 141.46% 5Y
+88.58 592.11% 10Y
NYSE, Closing price Tue, Feb 04 2025
+0.47 0.46%
ISIN
US1011371077
Symbol
BSX
Sector

Key metrics

Market capitalization $152.60b
Enterprise Value $161.53b
P/E (TTM) P/E ratio 85.64
EV/FCF (TTM) EV/FCF 74.92
EV/Sales (TTM) EV/Sales 10.15
P/S ratio (TTM) P/S ratio 9.59
P/B ratio (TTM) P/B ratio 7.37
Revenue growth (TTM) Revenue growth 15.65%
Revenue (TTM) Revenue $15.91b
EBIT (operating result TTM) EBIT $2.62b
Free Cash Flow (TTM) Free Cash Flow $2.16b
Cash position $2.57b
EPS (TTM) EPS $1.21
P/E forward 79.06
P/S forward 9.19
EV/Sales forward 9.73
Short interest 0.98%
Show more

Is Boston Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Boston Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

36 Analysts have issued a Boston Scientific forecast:

31x Buy
86%
5x Hold
14%

Analyst Opinions

36 Analysts have issued a Boston Scientific forecast:

Buy
86%
Hold
14%

Financial data from Boston Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
15,910 15,910
16% 16%
100%
- Direct Costs 5,981 5,981
13% 13%
38%
9,929 9,929
17% 17%
62%
- Selling and Administrative Expenses 4,552 4,552
18% 18%
29%
- Research and Development Expense 1,519 1,519
10% 10%
10%
3,858 3,858
19% 19%
24%
- Depreciation and Amortization 1,235 1,235
5% 5%
8%
EBIT (Operating Income) EBIT 2,623 2,623
27% 27%
16%
Net Profit 1,791 1,791
46% 46%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Boston Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Boston Scientific Stock News

Positive
Reuters
about 3 hours ago
Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.
Neutral
PRNewsWire
about 4 hours ago
MARLBOROUGH, Mass. , Feb. 5, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024, growing 22.4 percent on a reported basis, 23.1 percent on an operational1 basis and 19.5 percent on an organic2 basis, all compared to the prior year period.
Neutral
PRNewsWire
20 days ago
First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Ablation System Sub-analysis from OPTION clinical trial highlights consistent safety and efficacy outcomes with the WATCHMAN FLX™ Left Atrial Appendage Closure Device post cardiac ablation in both con...
More Boston Scientific News

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Head office United States
CEO Michael Mahoney
Employees 48,000
Founded 1979
Website www.bostonscientific.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today